ECHOSTAR CORP-A (SATS) Fundamental Analysis & Valuation

NASDAQ:SATS • US2787681061

Current stock price

127.73 USD
-0.95 (-0.74%)
Last:

This SATS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. SATS Profitability Analysis

1.1 Basic Checks

  • SATS had positive earnings in the past year.
  • In the past year SATS has reported a negative cash flow from operations.
  • In multiple years SATS reported negative net income over the last 5 years.
  • SATS had a positive operating cash flow in 4 of the past 5 years.
SATS Yearly Net Income VS EBIT VS OCF VS FCFSATS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5B -10B

1.2 Ratios

  • SATS has a Return On Assets of -33.70%. This is in the lower half of the industry: SATS underperforms 75.82% of its industry peers.
  • The Return On Equity of SATS (-251.43%) is worse than 75.82% of its industry peers.
Industry RankSector Rank
ROA -33.7%
ROE -251.43%
ROIC N/A
ROA(3y)-12.29%
ROA(5y)-6.56%
ROE(3y)-86.86%
ROE(5y)-50.67%
ROIC(3y)N/A
ROIC(5y)N/A
SATS Yearly ROA, ROE, ROICSATS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150 -200 -250

1.3 Margins

  • SATS's Gross Margin of 25.82% is on the low side compared to the rest of the industry. SATS is outperformed by 64.84% of its industry peers.
  • SATS's Gross Margin has declined in the last couple of years.
  • SATS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-23.13%
GM growth 5Y-15.68%
SATS Yearly Profit, Operating, Gross MarginsSATS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. SATS Health Analysis

2.1 Basic Checks

  • SATS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for SATS has been increased compared to 1 year ago.
  • The number of shares outstanding for SATS has been increased compared to 5 years ago.
  • SATS has a worse debt/assets ratio than last year.
SATS Yearly Shares OutstandingSATS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
SATS Yearly Total Debt VS Total AssetsSATS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • Based on the Altman-Z score of 0.65, we must say that SATS is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.65, SATS is in line with its industry, outperforming 46.15% of the companies in the same industry.
  • SATS has a Debt/Equity ratio of 3.24. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of SATS (3.24) is worse than 73.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.24
Debt/FCF N/A
Altman-Z 0.65
ROIC/WACCN/A
WACC9.11%
SATS Yearly LT Debt VS Equity VS FCFSATS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B 20B 25B

2.3 Liquidity

  • SATS has a Current Ratio of 0.42. This is a bad value and indicates that SATS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • SATS has a Current ratio of 0.42. This is amonst the worse of the industry: SATS underperforms 80.22% of its industry peers.
  • SATS has a Quick Ratio of 0.42. This is a bad value and indicates that SATS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • SATS has a worse Quick ratio (0.38) than 82.42% of its industry peers.
Industry RankSector Rank
Current Ratio 0.42
Quick Ratio 0.38
SATS Yearly Current Assets VS Current LiabilitesSATS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. SATS Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 1628.89% over the past year.
  • The Earnings Per Share has been growing by 49.00% on average over the past years. This is a very strong growth
  • The Revenue has decreased by -5.18% in the past year.
  • SATS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 51.37% yearly.
EPS 1Y (TTM)1628.89%
EPS 3Y49%
EPS 5YN/A
EPS Q2Q%-441.46%
Revenue 1Y (TTM)-5.18%
Revenue growth 3Y95.83%
Revenue growth 5Y51.37%
Sales Q2Q%-4.31%

3.2 Future

  • The Earnings Per Share is expected to decrease by -15.91% on average over the next years. This is quite bad
  • The Revenue is expected to decrease by -0.25% on average over the next years.
EPS Next Y-153.58%
EPS Next 2Y-55.78%
EPS Next 3Y-48.43%
EPS Next 5Y-15.91%
Revenue Next Year-3.41%
Revenue Next 2Y-2.74%
Revenue Next 3Y-2.61%
Revenue Next 5Y-0.25%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SATS Yearly Revenue VS EstimatesSATS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B
SATS Yearly EPS VS EstimatesSATS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 -10 -20 -30 -40

More info and screens

Find the best growth stocksShow best growing peers

1

4. SATS Valuation Analysis

4.1 Price/Earnings Ratio

  • SATS is valuated rather expensively with a Price/Earnings ratio of 18.57.
  • Based on the Price/Earnings ratio, SATS is valued a bit cheaper than the industry average as 72.53% of the companies are valued more expensively.
  • SATS is valuated rather cheaply when we compare the Price/Earnings ratio to 26.17, which is the current average of the S&P500 Index.
  • The Forward Price/Earnings Ratio is negative for SATS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 18.57
Fwd PE N/A
SATS Price Earnings VS Forward Price EarningsSATS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

  • SATS's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 39.53
SATS Per share dataSATS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

  • SATS's earnings are expected to decrease with -48.43% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-55.78%
EPS Next 3Y-48.43%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SATS Dividend Analysis

5.1 Amount

  • SATS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SATS Fundamentals: All Metrics, Ratios and Statistics

ECHOSTAR CORP-A

NASDAQ:SATS (4/6/2026, 12:27:02 PM)

127.73

-0.95 (-0.74%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)03-02
Earnings (Next)05-07
Inst Owners96.74%
Inst Owner Change0%
Ins Owners12.11%
Ins Owner Change1.92%
Market Cap36.90B
Revenue(TTM)15.00B
Net Income(TTM)-14.50B
Analysts76.36
Price Target109.82 (-14.02%)
Short Float %23.12%
Short Ratio5.1
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)339.66%
Min EPS beat(2)-463.29%
Max EPS beat(2)1142.6%
EPS beat(4)2
Avg EPS beat(4)174.08%
Min EPS beat(4)-463.29%
Max EPS beat(4)1142.6%
EPS beat(8)3
Avg EPS beat(8)88.21%
EPS beat(12)6
Avg EPS beat(12)20.43%
EPS beat(16)8
Avg EPS beat(16)28.88%
Revenue beat(2)0
Avg Revenue beat(2)-3.28%
Min Revenue beat(2)-5.46%
Max Revenue beat(2)-1.09%
Revenue beat(4)0
Avg Revenue beat(4)-3.22%
Min Revenue beat(4)-5.46%
Max Revenue beat(4)-1.09%
Revenue beat(8)0
Avg Revenue beat(8)-2.77%
Revenue beat(12)1
Avg Revenue beat(12)-3.2%
Revenue beat(16)4
Avg Revenue beat(16)-2.11%
PT rev (1m)-7.11%
PT rev (3m)24.23%
EPS NQ rev (1m)17.17%
EPS NQ rev (3m)17.17%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.45%
Revenue NQ rev (1m)-0.56%
Revenue NQ rev (3m)-0.16%
Revenue NY rev (1m)-0.83%
Revenue NY rev (3m)-0.59%
Valuation
Industry RankSector Rank
PE 18.57
Fwd PE N/A
P/S 2.46
P/FCF N/A
P/OCF N/A
P/B 6.4
P/tB 6.46
EV/EBITDA 39.53
EPS(TTM)6.88
EY5.39%
EPS(NY)-3.69
Fwd EYN/A
FCF(TTM)-3.69
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS51.94
BVpS19.96
TBVpS19.77
PEG (NY)N/A
PEG (5Y)N/A
Graham Number55.58
Profitability
Industry RankSector Rank
ROA -33.7%
ROE -251.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.82%
FCFM N/A
ROA(3y)-12.29%
ROA(5y)-6.56%
ROE(3y)-86.86%
ROE(5y)-50.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-23.13%
GM growth 5Y-15.68%
F-Score3
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 3.24
Debt/FCF N/A
Debt/EBITDA 12.49
Cap/Depr 60.91%
Cap/Sales 6.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.42
Quick Ratio 0.38
Altman-Z 0.65
F-Score3
WACC9.11%
ROIC/WACCN/A
Cap/Depr(3y)111.73%
Cap/Depr(5y)101.51%
Cap/Sales(3y)11.48%
Cap/Sales(5y)15.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1628.89%
EPS 3Y49%
EPS 5YN/A
EPS Q2Q%-441.46%
EPS Next Y-153.58%
EPS Next 2Y-55.78%
EPS Next 3Y-48.43%
EPS Next 5Y-15.91%
Revenue 1Y (TTM)-5.18%
Revenue growth 3Y95.83%
Revenue growth 5Y51.37%
Sales Q2Q%-4.31%
Revenue Next Year-3.41%
Revenue Next 2Y-2.74%
Revenue Next 3Y-2.61%
Revenue Next 5Y-0.25%
EBIT growth 1Y70.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year125.85%
EBIT Next 3Y32%
EBIT Next 5Y18.28%
FCF growth 1Y-263.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-107.93%
OCF growth 3YN/A
OCF growth 5YN/A

ECHOSTAR CORP-A / SATS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ECHOSTAR CORP-A?

ChartMill assigns a fundamental rating of 1 / 10 to SATS.


What is the valuation status of ECHOSTAR CORP-A (SATS) stock?

ChartMill assigns a valuation rating of 1 / 10 to ECHOSTAR CORP-A (SATS). This can be considered as Overvalued.


Can you provide the profitability details for ECHOSTAR CORP-A?

ECHOSTAR CORP-A (SATS) has a profitability rating of 1 / 10.


What is the valuation of ECHOSTAR CORP-A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ECHOSTAR CORP-A (SATS) is 18.57 and the Price/Book (PB) ratio is 6.4.


How financially healthy is ECHOSTAR CORP-A?

The financial health rating of ECHOSTAR CORP-A (SATS) is 0 / 10.